Insider Buying: Anteris Technologies Global (NASDAQ:AVR) Director Purchases $102,190.00 in Stock

Anteris Technologies Global Corp. (NASDAQ:AVR) Director Susan Elizabeth Knight acquired 11,000 shares of the business’s stock in a transaction on Tuesday, June 2nd. The shares were bought at an average cost of $9.29 per share, for a total transaction of $102,190.00. Following the acquisition, the director owned 11,000 shares of the company’s stock, valued at $102,190. This represents a ∞ increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Anteris Technologies Global Trading Down 0.1%

AVR stock opened at $9.64 on Friday. Anteris Technologies Global Corp. has a twelve month low of $2.85 and a twelve month high of $10.14. The company’s 50 day moving average is $6.83 and its two-hundred day moving average is $5.86. The stock has a market cap of $938.36 million, a P/E ratio of -4.32 and a beta of 1.78.

Anteris Technologies Global (NASDAQ:AVR) last released its quarterly earnings data on Tuesday, May 12th. The company reported ($0.28) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.01). Anteris Technologies Global had a negative return on equity of 124.76% and a negative net margin of 5,148.78%.The company had revenue of $0.49 million for the quarter, compared to analyst estimates of $0.77 million. During the same period in the previous year, the business posted ($0.61) EPS. On average, equities research analysts predict that Anteris Technologies Global Corp. will post -1.14 earnings per share for the current year.

Analyst Ratings Changes

A number of analysts have weighed in on AVR shares. Barclays raised their price objective on shares of Anteris Technologies Global from $17.00 to $18.00 and gave the stock an “overweight” rating in a report on Friday, May 15th. Weiss Ratings reissued a “sell (d-)” rating on shares of Anteris Technologies Global in a report on Friday, May 29th. Wells Fargo & Company assumed coverage on shares of Anteris Technologies Global in a report on Wednesday, March 11th. They issued an “overweight” rating and a $16.00 target price on the stock. Wall Street Zen raised shares of Anteris Technologies Global from a “sell” rating to a “hold” rating in a report on Saturday, May 16th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $15.00 target price on shares of Anteris Technologies Global in a report on Friday, March 27th. Four investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $16.00.

Hedge Funds Weigh In On Anteris Technologies Global

A number of institutional investors have recently modified their holdings of AVR. Russell Investments Group Ltd. increased its holdings in shares of Anteris Technologies Global by 76.9% in the 3rd quarter. Russell Investments Group Ltd. now owns 6,536 shares of the company’s stock valued at $29,000 after acquiring an additional 2,841 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new position in shares of Anteris Technologies Global in the 1st quarter valued at $32,000. BNP Paribas Financial Markets increased its holdings in shares of Anteris Technologies Global by 83.3% in the 3rd quarter. BNP Paribas Financial Markets now owns 9,469 shares of the company’s stock valued at $43,000 after acquiring an additional 4,302 shares during the period. Bank of America Corp DE increased its holdings in shares of Anteris Technologies Global by 35.7% in the 3rd quarter. Bank of America Corp DE now owns 10,631 shares of the company’s stock valued at $48,000 after acquiring an additional 2,798 shares during the period. Finally, Duncan Williams Asset Management LLC acquired a new position in shares of Anteris Technologies Global in the 4th quarter valued at $54,000.

Anteris Technologies Global Company Profile

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.